Showing results (141-150 of 2,880) with videos related to
Sort By:
Pageof 288
Expert Opinion on Pharmacotherapy|January 29, 2010
Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trialChee W Khoo, Gregory Y H LipExpert Opinion on Pharmacotherapy|November 13, 2015
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillationMikhail S Dzeshka, Gregory Y H LipArrhythmia & Electrophysiology Review|February 3, 2016
Monitoring the Effects and Antidotes of the Non-vitamin K Oral AnticoagulantsNur A Rahmat, Gregory Y H LipPlos Medicine|June 1, 2021
Hypertension and atrial fibrillation: Closing a virtuous circleYing X Gue, Gregory Y H LipCritical Pathways in Cardiology|February 16, 2022
The Patient Pathway Review for Atrial FibrillationChun Shing Kwok, Gregory Y H LipEuropean Heart Journal. Quality of Care & Clinical Outcomes|September 12, 2023
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040Elizabeth M Camacho, Gregory Y H LipJournal of Atrial Fibrillation|December 14, 2016
Stroke And Bleeding Risk Assessment: Where Are We Now?Mikhail S Dzeshka, Gregory Y H LipClinical Research in Cardiology : Official Journal of the German Cardiac Society|April 12, 2017
The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature reviewRaffaele De Caterina, Gregory Y H LipCurrent Vascular Pharmacology|August 24, 2004
Diabetes, the renin-angiotensin system and heart diseaseHoong Sern Lim, Gregory Y H LipEuropean Journal of Heart Failure|July 25, 2006
Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?Aun-Yeong Chong, Gregory Y H LipPageof 288